BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Prague
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Perth
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:AWST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260426
DTSTAMP:20260425T020015
CREATED:20251121T002635Z
LAST-MODIFIED:20260106T022226Z
UID:10000212-1776902400-1777161599@melanoma.org.au
SUMMARY:22nd EADO Congress 2026
DESCRIPTION:The 22nd EADO Congress\, hosted by European Association of Dermato-Oncology\, will be held in Prague\, Czech Republic from April 23 to 25 2026. Attendance can be in-person or virtual. \nThe EADO Congress is the largest conference in dermato-oncology worldwide. Over 1\,000 participants from Europe and around the world are expected to attend. \nThe meeting provides updated scientific and clinical achievements in a wide spectrum of skin tumors\, including melanoma\, keratinocyte carcinomas\, and rare malignant neoplasms. The world’s leading experts have been invited as speakers and will offer you the opportunity to gain comprehensive insight into all areas of dermato-oncology. \nPrague is the political\, cultural\, and historical center of the Czech Republic. The Congress Centre O2 Universum offers state-of-the-art meeting facilities in a vibrant and accessible location. With excellent public transport connections and modern amenities\, the venue provides the perfect setting for an unforgettable congress experience. \nLocation: O2 Universum\, Ceskomoravska 2345/17a\, 19000 Prague\, Czech Republic \nKey Dates: \nDeadline for Abstracts: January 15\, 2026 (6:00pm CET) \nDeadline for Late-breaking & Trials in progress Abstracts: February 6\, 2026 \nEvery on-site ticket purchased before April 13\, 2026\, includes a ticket for public transportation (valid for 72 hours). \n\n\n\nFIND OUT MORE
URL:https://melanoma.org.au/event/2026-eado-congress/
LOCATION:O2 Universum\, Ceskomoravska 2345/17a\, Prague\, 19000\, Czech Republic
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/11/EADO-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260430
DTEND;VALUE=DATE:20260504
DTSTAMP:20260425T020015
CREATED:20251201T222256Z
LAST-MODIFIED:20251202T033629Z
UID:10000219-1777507200-1777852799@melanoma.org.au
SUMMARY:RACS Annual Scientific Congress 2026
DESCRIPTION:The Royal Australasian College of Surgeons (RACS) Annual Scientific Congress (ASC) 2026 marks the 94th RACS ASC and promises to be an inspiring and future-focused event\, uniting surgeons\, scientists\, innovators\, and thought leaders from across the surgical and broader healthcare ecosystem. \nHosted at the Perth Convention and Exhibition Centre from Thursday 30 April to Sunday 3 May 2026\, the RACS ASC will centre on the theme: The Art and Science of Collaboration. \nIn surgery\, progress is never made in isolation. This year\, we shine a spotlight on the many ways in which surgeons collaborate—with each other\, with scientists and researchers\, with industry\, biomedical engineers and policy makers\, with emerging technologies\, and of course with our patients. From the precision of robotics to the nuance of communication\, the RACS ASC 2026 will explore how meaningful collaboration drives innovation and improves outcomes. \nLocation: Perth Convention and Exhibition Centre\, Perth \nKey Dates: \nAbstract Submissions Close: 8:00am AWST\, Tuesday 27 January 2026 \nAbstract Notifications: March 2026 \nClosure of Early Registration: 11:59pm AWST\, Sunday 15 March 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/racs-annual-scientific-congress-2026/
LOCATION:Perth Convention and Exhibition Centre\, 21 Mounts Bay Rd\, Perth\, WA\, 6000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/12/RACS-Congress.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260430T170000
DTEND;TZID=Australia/Sydney:20260430T170000
DTSTAMP:20260425T020015
CREATED:20260303T004445Z
LAST-MODIFIED:20260303T004445Z
UID:10000264-1777568400-1777568400@melanoma.org.au
SUMMARY:Australian Melanoma Research Foundation Research Grants
DESCRIPTION:The AMRF will continue to support the next generation of melanoma researchers in Australia by providing research grants to post-graduate students and early career researchers. \nThe AMRF will fund research that contributes to the understanding and prevention of melanoma. The number of grants awarded in 2026 will depend on the quality of the applications and the funds requested. The AMRF will be selective in the research it supports. Any proposal to the Foundation for research funding will need to be contestable and show evidence of scientific merit within the national context. \nThe aim of the AMRF’s grants scheme is to support high quality research that is not fully funded through other grant schemes or from other sources.  AMRF funds are to be applied to offset the direct costs of the research. The proposed research may be part of an existing  research program.  However\, the application to the AMRF should be for a stand-alone component of that existing project. \nApplications for funding will be assessed against several of the following criteria: \n\nPublication history in melanoma (by the applicant and/or their supervisor)\nEvidence of scientific merit and clinical need within the national context\nProposed dissemination of research findings\nBroader impact on education and awareness of melanoma\n\nKey Dates\nEOIs close: 30 April 2026\nFull applications deadline: 25 May 2026\nSuccessful applicants announced: 15 June 2026\nFunds available: by 30 June 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/amrf-research-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/AMRF-Research-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260430T170000
DTEND;TZID=Australia/Sydney:20260430T170000
DTSTAMP:20260425T020015
CREATED:20260303T011942Z
LAST-MODIFIED:20260303T011942Z
UID:10000266-1777568400-1777568400@melanoma.org.au
SUMMARY:NSW Translational Research Grants Scheme
DESCRIPTION:Funding research projects that translate into better patient outcomes\, health service delivery\, and population health and wellbeing \nThe Translational Research Grants Scheme aims to: \n\nfoster the generation of high-quality research that is directly relevant to clinical\, health service and population health practice in NSW\nenhance health and medical research capability and capacity within the NSW health system\nsupport projects that have the potential to be translated into policy and practice\, including research that can be generalised and scaled in other LHDs/SHNs across the state\nreduce the time from evidence generation to practice implementation.\n\nHost organisations must identify and engage relevant partners to support effective delivery of the research project and implementation of the outcomes in NSW. \nRound 10 NOW OPEN. \nKey Dates\nEOI due to Host Organisation: 30 April 2026\nFull application due to Host Organisation: 31 July 2026\nFull applications due to NSW Ministry of Health\, Office for Health and Medical Research: 28 August 2026\nSuccessful applicants notified: Late February 2027\nResearch begins: 1 July 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nsw-translational-research-grants/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NSW-Health-Translational-Research-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR